Clinical Trial Update: BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection [Phase 2, Phase 3]

View source ↗

Summary

This update outlines the BREATHER short-cycle therapy trial (5 days on/2 days off) for HIV-infected youth, spanning Phase 2 and Phase 3, with no results reporte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: PENTA Foundation | Conditions: HIV | Phase 2, Phase 3 | Status: UNKNOWN